ViewRay (VRAY) Stock Price, News & Analysis

Company Overview

ViewRay, Inc. designs, manufactures, and markets magnetic resonance imaging (MRI) guided radiation therapy systems to image and treat cancer patients in the United States, Italy, France, Taiwan, the United Kingdom, and internationally. It provides MRIdian, which is an MRI guided radiation therapy system that addresses beam distortion, skin toxicity, and other concerns. The company serves university research and teaching hospitals, community hospitals, private practices, government institutions, and freestanding cancer centers through a network of direct sales force and distributors. ViewRay, Inc. was founded in 2004 and is headquartered in Denver, Colorado.

Key Stats

• Today's Range: N/A
• 50-Day Range: $0.03 to $0.65
• 52-Week Range: N/A
• Volume: 108.50 million shs
• Average Volume: 7.51 million shs
• Market Capitalization: $4.59 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

ViewRay Stock Analysis - MarketRank™

ViewRay scored higher than 10% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for ViewRay.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of ViewRay is -0.04, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of ViewRay is -0.04, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for VRAY.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

ViewRay does not currently pay a dividend.

Dividend Growth

ViewRay does not have a long track record of dividend growth.

Sustainability and ESG

• Score: 4.4 / 5
• Environmental Score: -1.55

Short Interest

There is no current short interest data available for VRAY.

News and Social Media

• Score: 0.6 / 5
• News Sentiment: N/A

MarketBeat Follows

1 people have added ViewRay to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, ViewRay insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 2.50% of the stock of ViewRay is held by insiders.

Percentage Held by Institutions

92.97% of the stock of ViewRay is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

VRAY Stock Analysis - Frequently Asked Questions

How were ViewRay's earnings last quarter?

ViewRay, Inc. (NASDAQ:VRAY) released its quarterly earnings data on Monday, February, 27th. The company reported ($0.15) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.16) by $0.01. The firm's quarterly revenue was up 70.1% compared to the same quarter last year.

Does ViewRay have any subsidiaries?

The following companies are subsidiaries of ViewRay: Vesuvius Acquisition Corp., ViewRay GmbH, and ViewRay Technologies Inc..

When did ViewRay IPO?

ViewRay (VRAY) raised $52 million in an IPO on the week of April 6th 2015. The company issued 4,000,000 shares at a price of $12.00-$14.00 per share. Cowen and Company and Stifel acted as the underwriters for the IPO and BTIG and Brean Capital were co-managers.

What other stocks do shareholders of ViewRay own?

Based on aggregate information from My MarketBeat watchlists, some other companies that ViewRay investors own include Alibaba Group (BABA), Meta Platforms (META), Sorrento Therapeutics (SRNE), Advanced Micro Devices (AMD), NVIDIA (NVDA), Bristol-Myers Squibb (BMY) and Amarin (AMRN).

Company Calendar

• Last Earnings: 2/27/2023
• Today: 1/29/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Electromedical equipment
• Sub-Industry: N/A
• Current Symbol: NASDAQ:VRAY
• CUSIP: N/A
• CIK: 1597313
• Web: www.viewray.com
• Phone: (440) 703-3210
• Fax: 800-417-3459
• Employees: 295
• Year Founded: 2004

Profitability

• EPS (Most Recent Fiscal Year): ($0.60)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-107,330,000.00
• Net Margins: -104.30%
• Pretax Margin: -104.30%
• Return on Equity: -120.48%
• Return on Assets: -42.39%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.16
• Quick Ratio: 0.91

Sales & Book Value

• Annual Sales: $105.86 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.45 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 183,402,000
• Free Float: 178,817,000
• Market Cap: $4.59 million
• Optionable: Optionable
• Beta: 0.81